Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[EX Q]: "The world’s fastest man says he’s not scared of Zika since he can always outrun virus-carrying mosquitoes. Jamaican sprinter Usain Bolt, who is preparing for this summer’s Olympic games, was asked recently about the Zika epidemic in the host country of Brazil. No worries, he said. ""Because I’m fast,"" he joked in a May 18 interview on NBC’s Today. ""They can’t catch me."" This should be obvious: We are not saying that running is a Zika prevention method. (Here are some actual steps to take to avoid being bitten.) But we were curious whether Bolt really would outpace the mosquito. (People already have tried to figure out if Bolt can beat a cheetah. He can’t.) To the stat sheet! Bolt currently holds both the 100 meter and 200 meter world records at 9.58 seconds and 19.19 seconds respectively. That corresponds to 23.35 miles per hour for the 100-meter dash, and 23.31 miles per hour for the 200-meter dash. Based on how he’s performed in all past races listed by the International Association of Athletics Federations, Bolt’s average speed is 21.65 miles per hour. Even at his slowest, when he clocked 48.28 seconds at the 400-meter in 2001, he was still running at 18.53 miles per hour. The New York Times did an excellent job breaking down Bolt’s prowess in this video from the 2012 Olympics. So Bolt runs — in short bursts — around 22 miles per hour. How does that stack up against mosquitoes? Many mosquito species in the Aedes genus (africanus, apicoargenteus, luteocephalus, vitattus, furcifer, albopictus, hensilli and polynesiensis) can transmit the Zika virus, but the main vector is Aedes aegypti. Female aegypti mosquitoes (the ones that bite) are estimated to have a cruising speed of 0.5 to 1.5 meters per second. That’s the equivalent of 1.12 to 3.35 miles per hour — a fraction of Bolt’s speed, even at his slowest. In that sense, it’s not a contest. Until you factor in stamina. Bolt runs short distances, while the mosquitoes are in it for the long haul. Researchers have documented lady aegypti flying continuously for two to nine hours, with an average of 2.2 hours. So Bolt, or really anyone, would have to run more than 7.37 miles in that time frame to outpace the mosquito. Kenya’s Dennis Kimetto, Bolt’s world record counterpart in the marathon world, ran 26.219 miles in 2 hours, 2 minutes and 57 seconds. He’d leave the mosquito nearly 20 miles behind with that pace. Kimetto. (AP) Bolt and Kimetto would have a lot more to worry about if the Zika vector was a desert locust or earworm, which have respective average air speeds of 21 and 17 miles per hour. But for now, Zika-carrying mosquitoes can’t catch up to either man. Our ruling Bolt said Zika mosquitoes ""can’t catch me."" The Olympic champion and world record holder clocks an average speed is 21.65 miles per hour in his races, with 23.35 miles per hour at the high end and 18.53 miles per hour at the low end. Female A. aegypti mosquitoes, the main vector for Zika, cruise between 1.12 and 3.35 miles per hour. That’s a lot slower than Bolt, though the mosquitoes fly for much longer than Bolt sprints. Don’t try this, people. (But if you do, send us a video!)
[EX A]: "Zika mosquitoes ""can’t catch me."

[EX Q]: "There is no mention of cost. The story could have at least reported what the drug costs in its current use against blood cancer. The story did a good job of explaining both the potential benefits and harms of the drugs. This was a particular strength of this story – and made it stand out in comparison with the LA Times blog story that we also reviewed. Harms were emphasized from the outset – even in the headline – in the AP story but were never mentioned in the LA Times story. And this story reminded readers of the side effects encountered with another MS drug, Tysabri. Outstanding job on this issue by the AP. The story did a very good job of explaining the studies. There is no sign of disease-mongering in this story. Two apparently independent sources were quoted. The story did a good job comparing the new drugs with existing approaches to treat MS. Story explains that the drug is already sold to treat a rare blood cancer and stated that ""it’s too soon to know if the pills will be approved by the government or widely adopted by physicians."" It does not report, however, as the LA TImes blog did, that ""The drug company MD Serono, an affiliate of Merck, has requested approval from the Food and Drug Administration to market the tablet. However it recently received a ""refuse to file"" letter from the FDA, which means the agency is requiring additional information or data. MD Serono said it is pursuing the matter with the FDA and hopes to re-submit its application."" We think that’s a crucial piece of information that affects availability, although, of course, doctors can still prescribe it for off-label use even before the FDA acts on the new request. The novelty of ""tests of the first two oral drugs developed for treating MS"" was clear in the story. It is clear that this story did not rely on a news release."
[EX A]: MS pills show promise and risk, studies say

[EX Q]: The charity’s board chair, Carrie Coghill, says the idea is for the award to be seen as similar to a Nobel Prize for women’s health. The Richard King Mellon Foundation is funding the effort. The group’s efforts are built around three goals. The 9-90 program focuses on identifying and curing illnesses originate while a person is in the womb, but which can last for 90 years, or a lifetime. The group also seeks research into gender specific biological and medical problems that affect women only, and for efforts to reduce or eliminate HIV/AIDS globally. The summit will be held Oct. 8-10, 2018.
[EX A]:
Pittsburgh-based Magee-Womens institute to offer $1M prize.